R. Carruthers
Director of Finance/CFO bei EDGEWISE THERAPEUTICS, INC.
Vermögen: 529 398 $ am 31.03.2024
Profil
R.
Michael Carruthers is currently the Director at OnKure, Inc., the Independent Director at Elevation Oncology, Inc., and the Chief Financial Officer at Edgewise Therapeutics, Inc. Previously, he held positions as the Director at Pyxant Labs, Inc., Treasurer & Controller-Waukesha Division at Dover Corp., Chief Financial Officer at Vical, Inc., Chief Financial & Accounting Officer at Array BioPharma, Inc., Accountant at Coopers & Lybrand LLP, Chief Financial Officer at Sievers Instruments, Inc., President, Chief Financial Officer & Secretary at Nivalis Therapeutics, Inc., President & Chief Financial Officer at Alpine Immune Sciences, Inc., Chief Financial Officer at ClinOne, Inc., and Chief Financial Officer at Fresh Tracks Therapeutics, Inc. He has an MBA from The University of Chicago and an undergraduate degree from the University of Colorado Boulder.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 23.01.2024 | 29 024 ( 0,03% ) | 529 398 $ | 31.03.2024 | |
ELEVATION ONCOLOGY, INC.
-.--% | 16.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von R. Carruthers
| Unternehmen | Position | Beginn |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Director of Finance/CFO | 16.10.2020 |
| ELEVATION ONCOLOGY, INC. | Director/Board Member | 18.05.2021 |
OnKure, Inc.
 OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | Director/Board Member | 01.03.2019 |
Ehemalige bekannte Positionen von R. Carruthers
| Unternehmen | Position | Ende |
|---|---|---|
| FRESH TRACKS THERAPEUTICS, INC. | Director of Finance/CFO | 01.10.2020 |
ClinOne, Inc.
 ClinOne, Inc. Packaged SoftwareTechnology Services ClinOne, Inc. develops mobile software application. The firm serves for sites and patients. It offers elaerning, screening, documents, videos, econsent, procedure manager, and adverse events services. The company was founded by Rob Bohacs and Eric Schraufnagel and is headquartered in Denver, CO. | Director of Finance/CFO | 01.05.2020 |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | President | 01.08.2017 |
| ALPINE IMMUNE SCIENCES, INC. | Director of Finance/CFO | 24.07.2017 |
| ARRAY TECHNOLOGIES, INC. | Director of Finance/CFO | - |
Ausbildung von R. Carruthers
| The University of Chicago | Masters Business Admin |
| University of Colorado Boulder | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| DOVER CORPORATION | Producer Manufacturing |
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| EDGEWISE THERAPEUTICS, INC. | Health Technology |
| FRESH TRACKS THERAPEUTICS, INC. | Health Technology |
| ELEVATION ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Pyxant Labs, Inc.
 Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | Commercial Services |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | Health Technology |
| Coopers & Lybrand LLP | Commercial Services |
Sievers Instruments, Inc.
 Sievers Instruments, Inc. Electronic Equipment/InstrumentsElectronic Technology Sievers Instruments, Inc. was the analytical instrument company, manufacturer of portable, laboratory and process total organic carbon (TOC) analyzers, elemental analyzers and element specific detectors for the gas chromatography. It offered a full range of instrumentation for measurement low levels of total organic carbon (TOC) in water, including: The Portable TOC Analyzer and TOC Autosampler, on-line pharmaceutical TOC analyzer, turbo reclaim TOC analyzer, ultrapure ppt TOC analyzer, on-line pharmaceutical TOC analyzer and ap pharmaceutical TOC Analyzer. Its line of instruments includes: sulfur specific analyzer (SSA), sulfur chemiluminescense detector (SCD), nitrogen chemiluminescense detector (NCD) and nitric oxide analyzer (NOA). The company was founded in 1984 and headquartered in Boulder, CO. | Electronic Technology |
ClinOne, Inc.
ClinOne, Inc. Packaged SoftwareTechnology Services ClinOne, Inc. develops mobile software application. The firm serves for sites and patients. It offers elaerning, screening, documents, videos, econsent, procedure manager, and adverse events services. The company was founded by Rob Bohacs and Eric Schraufnagel and is headquartered in Denver, CO. | Technology Services |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | Health Technology |
